북미 멀티플렉스 분석 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 북미 멀티플렉스 분석 시장

북미 멀티플렉스 분석 시장은 2021년부터 2028년까지의 예측 기간 동안 8.67%의 시장 성장을 목격할 것으로 예상됩니다. 북미 멀티플렉스 분석 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 항공 부문의 상승은 북미 멀티플렉스 분석 시장의 성장을 가속화하고 있습니다.

멀티플렉스 분석은 자기 또는 비자성 비드를 사용하여 단일 샘플에서 여러 분석 항목을 결정하는 면역 분석의 한 형태입니다. 멀티플렉스 분석은 ELISA 와 동일 하지만 멀티플렉스 분석에서 포획 항체를 결합하는 데 비드를 사용한다는 점이 다릅니다. 멀티플렉스 분석은 장점으로 인해 임상 환경보다 연구에서 점점 더 흔해지고 있습니다.

예측 기간 동안 북미 멀티플렉스 검사 시장 성장을 촉진할 것으로 예상되는 주요 요인은 만성 질환(주로 암) 의 증가 와 동반 진단에서 멀티플렉스 검사 사용 증가입니다. 또한, 싱글플렉스 및 기존 검사에 비해 멀티플렉스 검사의 이점, 기술 발전, 증가하는 의료비 지출, 다양한 질병 및 병리적 상태의 다인자적 특성에 대한 인식 증가는 북미 멀티플렉스 검사 시장 성장을 더욱 촉진할 것으로 예상됩니다.  

또한, 분자 및 단백질 진단에서 바이오마커 검증이 증가하고 처리량이 높고 자동화된 시스템에 대한 필요성이 커지면서 향후 몇 년 동안 북미 멀티플렉스 검사 시장이 성장할 수 있는 잠재적 기회가 제공될 것입니다.

그러나 장비와 관련된 높은 비용과 숙련된 노동력의 부족은 가까운 미래에 북미 멀티플렉스 분석 시장 성장에 더욱 큰 어려움을 줄 수 있습니다.

This North America multiplex assays market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Multiplex Assays Market Scope and Market Size

The North America multiplex assays market is segmented on the basis of product and services, type, technology, application and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of products and services, the North America multiplex assays market is segmented into reagents and consumables, instruments and accessories, and software and services.
• On the basis of type, the North America multiplex assays market is segmented into nucleic acid multiplex assays, protein multiplex assays, and cell-based multiplex assays. Protein multiplex assays have been further sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays have been further sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays.
• On the basis of technology, the North America multiplex assays market is segmented into protein microarray, polymerase chain reaction, multiplex real-time PCR, flow cytometry, fluorescence detection, luminescence and others.
• On the basis of application, the North America multiplex assays market is segmented into clinical diagnostics, research and development. Clinical diagnostics have been further sub-segmented into cancer, autoimmune diseases, infectious diseases, nervous system disorders, infectious diseases, allergies, metabolism and endocrinology disorders, cardiovascular diseases, and others. Research and development has been further sub-segmented into drug discovery and development and biomarker discovery and validation.
• On the basis of end users, the North America multiplex assays market is segmented into hospital, clinical laboratories, pharmaceutical and biotechnology companies, research institutes and others.

North America Multiplex Assays Market Country Level Analysis

The North America multiplex assays market is analysed and market size insights and trends are provided by country, product and services, type, technology, application and end-users as referenced above.

The countries covered in North America multiplex assays market report are U.S., Canada, and Mexico in North America.

United States dominates the North America multiplex assays market due to cancer being the second most common cause of death. Furthermore, the increase in the other chronic conditions will further boost the growth of the North America multiplex assays market during the forecast period.

The country section of the North America multiplex assays market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The North America multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America multiplex assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America multiplex assays market. The data is available for historic period 2010 to 2019.

Competitive Landscape and North America Multiplex Assays Market Share Analysis

The North America multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America multiplex assays market.

북미 멀티플렉스 검사 시장 보고서에서 다루는 주요 기업으로는 BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Cepheid, Siemens, Agena Bioscience, Inc., Hologic Inc., Luminex Corporation., MESO SCALE DIAGNOSTICS, LLC., QIAGEN, PerkinElmer Inc., Illumina, Inc., Olink, Agilent Technologies, Inc., Randox Laboratories Ltd., Bio-Techne., Sysmex Corporation 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

SKU-27497